🔴 McKesson is trading 5% down in pre-market as investors seek acquisition synergy clarity

McKesson is trading at $857.38 (-5.27%) as investors seek greater clarity on synergies from its previously announced acquisition.

• The $2.25 billion Precision Medicine Group acquisition initially supported shares; Reuters reported early-trading gains and investor requests for synergy clarity.
• McKesson is 5.27% down from the $905.09 August 25 close at 4:16 AM EST.
• No new overnight company-specific negative catalyst was identified; mixed index futures offer no strong market-wide explanation.